AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Why multibagger stock Aarti Drugs surged 12% today
Multibagger stock: In last 5 years, Aarti Drugs share price has appreciated from around 125 to 475 apiece levels AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company for Loss of share certificates AARTI DRUGS LTD. - 524348 - Intimation Of Approval Of Reclassification Of Promoter
Pursuant to the provisions of Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform that on August 8, 2022 the Company has received the approval letter from BSE Limited and National Stock Exchange of India Limited, for the application submitted for reclassification of Shareholding of Promoter/ Promoter Group to Public Category. AARTI DRUGS LTD. - 524348 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Aarti Drugs Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
This has reference to the 37th Annual General Meeting (AGM) of the Company which was held on Thursday, August 4, 2022 at 11:30 AM through Video Conferencing for the matters as stated in the Notice sent to the Shareholders. We would like to inform you that the resolution set forth in the notice have been passed by members of the Company with requisite majority. We are enclosing herewith the scrutinizer's report and voting results of the AGM. AARTI DRUGS LTD. - 524348 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting details of the proceedings of 37th Annual General Meeting (AGM) of the Company held on Thursday, August 4, 2022 at 11:30 AM through Video Conferencing. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached herewith presentation made to the shareholders of the Company at the 37th Annual General Meeting held today i.e. August 4, 2022 for your records. AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find attached herewith transcript of Q1 FY23 Earning Conference call.
Results Earnings Call for Q1FY23 of Aarti Drugs
Conference Call with Aarti Drugs Management and Analysts on Q1FY23 Performance and Outlook. Listen to the full earnings transcript.